Thread by @rheum_cat

At the GRA gathering, @jyazdanymd gives an overview of what @rheum_covid has accomplished since March 2020

The theme is the power of global collaboration

#ACR22

@JYazdanyMD @rheum_covid We've seen this slide many times but this is the final tally: >30k cases reported to @rheum_covid including the @eular registry

#ACR22

@JYazdanyMD @rheum_covid @eular 4 Major Contributions to Inform Patient Care and Policy

arising from work done by @rheum_covid

#ACR22

@JYazdanyMD @rheum_covid @eular 1️⃣early (and very warranted) caution regarding the use of #HCQ for treatment of COVID19

#HCQBrigade

#ACR22

@JYazdanyMD @rheum_covid @eular Works from the #HCQBrigade formed from members of @rheum_covid

The first of these was produced in <1 week in a collaborative writing process

A Rush to Judgment: pubmed.ncbi.nlm.nih.gov/32227189/
Festina Lente: pubmed.ncbi.nlm.nih.gov/32295786/
Swinging the Pendulum: pubmed.ncbi.nlm.nih.gov/32620062/

#ACR22

@JYazdanyMD @rheum_covid @eular Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

pubmed.ncbi.nlm.nih.gov/32381561/

#ACR22

@JYazdanyMD @rheum_covid @eular 2️⃣Early signal that RTX use is associated with higher risk of severe COVID19

pubmed.ncbi.nlm.nih.gov/33504483/

#ACR22

@JYazdanyMD @rheum_covid @eular 3️⃣Reassurance for those on TNF inhibitors - no signal for increased risk of severe COVID outcomes

pubmed.ncbi.nlm.nih.gov/34661663/

#ACR22

@JYazdanyMD @rheum_covid @eular 4️⃣Impact on COVID19 policies, and our work on disparities led by @izadizara @milenagianfran

pubmed.ncbi.nlm.nih.gov/35909441/
pubmed.ncbi.nlm.nih.gov/33146001/

#ACR22

@JYazdanyMD @rheum_covid @eular @IzadiZara @MilenaGianfran We are no longer accepting new cases to @rheum_covid but we are working on finalizing the last analyses for publication and dissemination



Thanks to all contributors to cases, the research, and other support

#ACR22